Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
In addition, when comparing the costs across AOMs, Wegovy makes up most of 2022 plan spending at 58.4 percent, followed by Saxenda at 39.1 percent, as shown in the graph below
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Monitoring at Home: Close observation is key
Most gastrointestinal side effects are dose-dependent and tend to diminish over time as patients develop tolerance, typically improving after 4-8 weeks at a stable dose
Find out more from this WebMD slideshow
US$ 26.50
US$ 20.47
US$ 25.72
